What is Biohaven's prepaid expenses?

Biohaven (BHVN) reported prepaid expenses of $34.67M in Q1 2026.

How has Biohaven's prepaid expenses changed year-over-year?

Biohaven's prepaid expenses decreased by 38.5% year-over-year, from $56.39M to $34.67M.

Over 4 years (2021 to 2025), Biohaven's prepaid expenses has grown at a 62.6% compound annual growth rate (CAGR), from $6.73M to $47.02M.

Eli LillyLLY

——

uniQureQURE

——

Immunovant, Inc.IMVT

——

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Market cap$2.25B-48.1%

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Biohaven's prepaid expenses?: Biohaven (BHVN) reported prepaid expenses of $34.67M in Q1 2026.
How has Biohaven's prepaid expenses changed year-over-year?: Biohaven's prepaid expenses decreased by 38.5% year-over-year, from $56.39M to $34.67M.
What is the long-term trend for Biohaven's prepaid expenses?: Over 4 years (2021 to 2025), Biohaven's prepaid expenses has grown at a 62.6% compound annual growth rate (CAGR), from $6.73M to $47.02M.